2m 2m 2m 2m 2m 2m 2m
CARIBOU BIO (CRBU)
NASDAQ
$1.29+$0.02 (+1.57%)
Price as of Sep 11, 2026 7:55 PM EDT- $136.2MMarket Cap
- -29.44%1-Year Change
- BiotechnologyIndustry
CARIBOU BIO (CRBU)
$1.29+$0.02 (+1.57%)
CRBU | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.27 | ||
Change | -$0.10 (-7.30%) | ||
Open | $1.38 | ||
High | $1.40 | ||
Low | $1.26 | ||
Previous Close | $1.37 | ||
Volume | 2,433,878 | ||
30-Day Average Volume | 1,095,567 | ||
1-Week Change | -19.11% | ||
1-Month Change | -24.85% | ||
1-Year Change | -29.44% | ||
3-Year Change | -80.13% | ||
5-Year Change | -95.60% | ||
Fundamentals | |||
Shares Outstanding | 107.2M | ||
Total Assets | $142.8M | ||
Market Cap | $136.2M | ||
Enterprise Value | $110.0M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$24.3M | ||
Free Cash Flow | -$22.8M | ||
EBIT | -$24.3M | ||
EBITDA | -$23.7M | ||
Net Working Capital | $98.6M | ||
EPS | -$0.24 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | -1 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue